Mankind Pharma Limited has informed the Exchange regarding a press release dated August 20, 2026, titled "Mankind Pharma Enters into Exclusive In-Licensing Agreement for Insulin Degludec and Insulin Degludec + Aspart Combination for India".
Mankind Pharma Ltd. Press Release Aug 20 2026
Earlier from Mankind Pharma
- Mankind Pharma Ltd. Press Release Jul 30 2026
- Press Release May 19 2026
- Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Press Release Mar 18 2026